Today it was reported that the SVP – Global Sales & Mktg. of Misonix (NASDAQ: MSON), Robert Ludecker, exercised options to buy 4,000 MSON shares at $4.68 a share, for a total transaction value of $18.72K.
This recent transaction increases Robert Ludecker’s holding in the company by 73.49% to a total of $161K.
See today’s analyst top recommended stocks >>
Based on Misonix’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $12.44 million and quarterly net profit of $2.24 million. In comparison, last year the company earned revenue of $7.89 million and had a GAAP net loss of $398.7K. Currently, Misonix has an average volume of 76.05K.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Misonix, Inc. is a medical device company that designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company’s ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.
